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their disease stage. The methodological framework here presented uses 
prevalent cohort survival data to reconstruct stage-specific survival rates, as 
they would be if obtained from an incident cohort. METHODS: This approach 
assumes proportional hazards and, under certain caveats, can be generalized to 
non-proportional hazards. Through a piece-wise back calculation approach 
recent survival data are fed and integrated into the model to calculate survival at 
earlier stages of the disease, this allows the reconstruction of the survival 
probability as a function of the time elapsed from the onset of illness. This 
method is then generalized to allow comparison between ‘placebo’ and 
‘treatment’ prevalent-cohorts. RESULTS: The method is very general and can be 
applied to a variety of cases. As an example, the only published data on an 
untreated tuberculosis prevalent cohort is used to infer the actual mortality rates 
of untreated tuberculosis through the course of the illness. The results show that 
mortality is highest within the first two years of illness, declining dramatically 
immediately after and increasing again to intermediate rates after one year, 
suggesting population heterogeneity with respect to the risk of dying from 
tuberculosis-related illness. In general, if sufficient data on a ‘placebo’ and on a 
‘treatment’ cohorts is available, this method can be used to infer the potential 
stage-specific effectiveness of a treatments. CONCLUSIONS: Under specific 
modeling assumptions, incident-cohort survival and treatment effect can be 
inferred from prevalent-cohort studies.  
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OBJECTIVES: Post-menopausal women are under-diagnosed in claims data even 
though they exhibit symptoms. Probabilistic linkage was conducted between 
claims data and The University of Michigan Women’s Registry data to control for 
post-menopausal symptoms as risk factors in the analysis. METHODS: Women 
with a menopause diagnosis who used estrogen only hormone therapy (HT) were 
selected from the registry data. A separate group of patients age 45 or older who 
were prescribed estrogen only HT was selected from a large U.S. claims database. 
Logistic regression was conducted to calculate the propensity score for each 
patient, controlling for women’s health-related comorbidities in each population. 
Patients with the closest propensity score from each group were matched, and 
the menopause symptoms of Registry patients were added to the claims records 
of the corresponding matched patients in the claims data. This linkage process 
was repeated 250 times, and the mean and 95% confidence interval (CI) of health 
care costs during the follow-up period were calculated. RESULTS: Among 2771 
women, 16% (N=443) were diagnosed as post-menopausal. Of this subset, 83 
patients prescribed estrogen only HT were selected. After probabilistic linking 
with the 20,020 selected women from the claims database, 80 patients from each 
population were matched. The average cost of patients with at least one 
symptom was much higher compared to patients without symptoms ($13,570 
[95% CI: $13,459-$13,680] vs. $3,391 [95% CI: $3,345-$3,436], p-value<0.001). Cost 
differences were mainly from inpatient ($1,997 [95% CI: $1,925-$2,070], p-
value<0.001 vs. $247 [95% CI: $239-$254, p-value<0.001), physician visit ($967 [95% 
CI: $961-$974], p-value<0.001 vs. $248 [95% CI: $246- $251], p-value<0.001), and 
pharmacy costs ($3,676 [95% CI: $3,648-$3,704], p-value<0.001 vs. $903 [95% CI: 
$890-$916], p-value<0.001). CONCLUSIONS: The study suggests that post-
menopausal symptoms are important risk factors to control when assessing 
health care costs in claims data. Probabilistic linkage can bridge the gap between 
claims and registry data information.  
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OBJECTIVES: To evaluate the equivalence of electronic and paper versions of the 
Psoriasis Symptom Inventory (PSI) and examine measurement properties of the 
electronic version. METHODS: In a prospective, randomized, cross-over, non-
interventional study in adult subjects (age ≥ 18 years) with plaque psoriasis 
conducted over a 15-day period , subjects were randomized to two groups, each 
completing either the paper or electronic PSI daily for 7 consecutive days 
followed by the alternate version. The disease specific Dermatology Life Quality 
Index [DLQI]) and the generic SF36v2 were also administered for evaluation of 
construct validity. Equivalence was assessed by the intraclass correlation 
coefficient (ICC) between both modes. Differences in scores between the 
administration modes were also tested using paired Student’s t-test. 
Measurement properties included internal consistency reliability, test-retest 
reliability, and construct validity. Convergent and discriminant validity were 
evaluated using pre-identified logical relationships between similar or distally 
related concepts. RESULTS: Eighty subjects (74% [59/80] moderate-to-severe 
psoriasis; 26% [21/80] mild psoriasis receiving systemic treatment) were enrolled 
from 8 sites in the United States. Seventeen (21%) subjects experienced a change 
in sPGA and were excluded from analyses. The paper and electronic modes of 
the PSI were highly concordant for both total scores (ICC = 0.969) and individual 
item scores (ICC range 0.934 to 0.965). Findings remained consistent (ICC values 
were all >0.91) irrespective of order of completion for the paper and electronic 
versions. All mean score differences were non-significant (p > 0.05) except for 
“flaking”; however, based on its reliability, validity, and clinical relevance, the 
item was retained. Minimum values for reliability (>0.70) and validity 
(convergent, r ≥ 0.30) were exceeded for the electronic PSI. CONCLUSIONS: 
Equivalence between paper and electronic versions of the PSI and the two 
modes’ comparable measurement properties indicated successful migration 
from paper to electronic format of the PSI.  
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OBJECTIVES: No standardized methods exist to measure outcomes related to 
Acute Bacterial Skin and Skin Structure Infections (ABSSSI). The purpose of this 
literature review was to identify clinical measurement concepts for other skin 
abnormalities that could be applied to ABSSSI. The results were used to inform 
the development of a standardized measurement tool and/or a novel Clinician 
Reported Outcome (ClinRO) for ABSSSI. METHODS: To identify relevant 
abstracts/articles for inclusion a search was conducted in OVID. MEDLINE (1946-
present) and EMBASE (1988-2012) were searched using terms related to ClinRO, 
measurement tools and devices, diagnostic tools, and skin 
diseases/abnormalities. RESULTS: The search identified 428 abstracts. 381 were 
excluded based on pre-specified criteria. The remaining 47 full-text articles were 
scrutinized for eligibility, resulting in 30 that met the inclusion criteria. No 
ABSSSI-specific ClinROs or measurement tools were identified in the literature. 
Several clinical concepts related to the measurement and evaluation of skin 
abnormalities were found e.g. Psoriasis Area and Severity Index; Vancouver Scar 
Scale; Pressure Ulcer Scale for Healing; Pressure Sore Status Tool and the Bates-
Jensen Wound Assessment Tool. Disease-severity instruments were also 
identified e.g. Severity Scoring of Atopic Dermatitis scale; Eczema Area and 
Severity Index; Investigators Global Assessment; Six Area, Six Sign Atopic 
Dermatitis severity index. Devices used to evaluate characteristics of skin 
abnormalities range from simple and inexpensive (ruler), to advanced and 
expensive (laser based tools). No single device was found that measures the full 
spectrum of a skin infection. CONCLUSIONS: There is a paucity of ABSSSI-
specific clinical endpoints/ClinRO measures in the existing literature. This 
review highlights the need to develop a standardized ClinRO instrument to 
assess clinical measurement concepts in ABSSSI. Robust scales, tools, and 
devices that measure or evaluate skin diseases and infections were identified. 
These could be considered when developing a standardized ABSSSI 
measurement tool and/or a novel ClinRO.  
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VALUING EQ-5D-5L: CAN LATENT UTILITIES DERIVED FROM A DISCRETE 
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OBJECTIVES: The EuroQol Group is evaluating the use of discrete choice 
experiments (DCEs) in valuing health states from the 5-level EQ-5D (EQ-5D-5L). 
Notably, a discrete choice (DC) model yields a latent utility that is ordinal and 
unbounded, whereas health utilities must have interval properties and be 
anchored at 0 (representing death) and 1 (representing full health). Latent 
utilities must therefore be transformed to health utilities. This pilot study 
investigated the feasibility of performing such a transformation. METHODS: 545 
respondents from Canada and 403 respondents from the UK each completed a 
series of DC and TTO tasks. Generalised linear mixed models were used to derive 
latent utilities. Linear regression models incorporating logarithmic and 
polynomial terms, as well as non-parametric LOESS and spline models were 
assessed as candidate functions for transforming the latent utilities onto the 
health utilities. RESULTS: There was a high correlation between health utilities 
measured through TTO tasks and latent utilities derived from modelling of DC 
data (Spearman rho of 0.79 in Canada and 0.86 in the UK). All transforming 
functions explained the between-state variation in health utilities, and, upon 
cross-validation, had minimal bias and small mean squared errors. Whilst the 
transformation functions derived through linear regression had the desirable 
feature of being monotone, the LOESS transform in Canada and the spline 
transform in the UK lacked monotonicity. CONCLUSIONS: This pilot study 
suggests that transforming latent utilities to health utilities is feasible, and 
provides preliminary evidence that linear regression involving polynomial and 
logarithmic terms may be more desirable than non-parametric spline or LOESS 
functions.  
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IS A PICTURE WORTH A THOUSAND WORDS? THE DEVELOPMENT OF A 
CLINICIAN AND PATIENT REPORTED PHOTONUMERIC GUIDE TO ASSESS SCAR 
SEVERITY  
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OBJECTIVES: Photo-based questionnaires have been used to evaluate aesthetic 
treatment outcomes such as wrinkle reduction and eyelash growth. The 
objective of this study was to develop a photonumeric guide of scar severity 
intended for use by both clinicians and patients to measure scar treatment 
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outcomes. METHODS: Nine clinicians and 43 patients with linear surgical scars 
participated in a photograph sorting exercise. Patients sorted approximately 50 
scar photographs consistent with their own skin type (light, medium or dark 
skin), while clinicians sorted all three sets of photographs (n=151 photographs). 
All participants arranged the photographs into 5 categories of perceived scar 
severity (least to most severe) and 5 photographs were considered for inclusion 
in the photonumeric guide based on analysis of inter-rater reliability, response 
consistency, redundancy, and variability. When photographs yielded similar 
results, clinical judgment was used to select the best photo. Instruction and 
response anchors were developed for the 5 scar photographs and the final guide 
was cognitively debriefed for relevance, comprehensibility, and acceptability in 
24 additional scar patients. RESULTS: Based on the pre-specified criteria for 
inclusion and exclusion, 5 light skin and 5 dark skin photographs were included 
in the final photonumeric guide. A “medium” guide was not developed because 
of significant overlap between it and the light skin guide rendering it 
superfluous. Inter-rater reliability of the 52 subject cohort was strong (0.95-0.96) 
across all skin types. The 5 photographs included in the photonumeric guide 
demonstrated goodness-of-fit (infit mean-square < 1.4 and > 0.6), low variance in 
severity ratings (SD < one category change), and strong agreement between 
patients and clinicians. CONCLUSIONS: The Patient and Clinician Reported Scar 
Severity Scales were systematically developed to easily assess scar severity 
outcomes in clinical trials. Continued psychometric evaluation of the guide is 
planned to ensure the scales meet regulatory standards for labeling purposes.  
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OBJECTIVES: To describe how pain descriptors are used to represent patients’ 
pain experiences by mapping word clusters identified by patients as synonyms 
for the same pain sensation. METHODS: Subjects were recruited by web posting 
and telephone screening. Those self-reporting current pharmacological 
treatment for Migraine, Low Back Pain (LBP), Osteoarthritis (OA), or Rheumatoid 
Arthritis (RA) were enrolled and completed in-person interviews using card sort 
exercises with 93 different pain descriptors. Subjects were asked to identify the 
descriptors they commonly used to describe the pain associated with their 
condition, and to isolate any pairs of words that describe the same pain 
sensation (‘linked’ descriptors). Network maps that diagrammed subject-
identified links between descriptors were created for each condition using 
Netdraw (Borgatti 2002) and compared. RESULTS: The 72 subjects ranged in age 
between 19 and 84 years (mean=45). Sixty-eight percent were female, 63% were 
working full- or part-time, and 61% were Caucasian. OA and Migraine subjects 
used more synonyms to describe similar pain experiences (14% and 10% of all 
identified synonym pairs, respectively) than the LBP and RA groups (at 7% and 
6%). For Migraine, most linked descriptors formed a single group of connections, 
or single integrated relationship. For the OA group, several smaller unassociated 
subgroups of synonyms were identified. For the LBP group, two main clusters 
emerged, differentiating low-intensity and high-intensity pain. For the RA group, 
several descriptors were weakly linked to only one other descriptor. Some 
synonyms were common to all four groups (e.g., STIFFNESS-TIGHTNESS), but 
others were condition-specific (e.g., SPREADING-RADIATING for OA, but 
SPREADING-GNAWING for Migraine). CONCLUSIONS: While some descriptors 
were used to convey a more consistent meaning across groups, other 
descriptors’ synonyms varied by condition, demonstrating condition-specific 
meaning. These findings emphasize the importance of tailoring item language to 
the specific population of interest when assessing pain with PRO instruments.  
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OBJECTIVES: To assess the construct validity of the Short Form-12 (SF-12) in 
type-1 diabetes (T1D). METHODS: This analysis used data from a study 
investigating factors affecting setting and attainment of HbA1c targets. A total of 
1,918 patients were recruited from the T1D exchange registry and completed a 
web-based survey; 1,846 of them finished the SF-12 section of the survey. The 
physical component score (PCS) and the mental component score (MCS) from SF-
12 were compared between known groups. The known groups were defined by 
treatment intensity, duration with disease, complication, hospitalization, 
emergency room visits, glycemic control and working. Parametric or 
nonparametric tests were used depending on the scale of the measure. The 
Diabetes Quality of Life (DQoL) Brief Clinical Inventory is a disease specific 
quality of life (QoL) measure, lower score indicates better QoL. The correlations 
between SF-12 scores and DQoL score were also examined. RESULTS: PCS and 
MCS had no association with more frequent insulin injections. PCS had a 
positive correlation (r=-0.22, p<0.05) with duration of disease while MCS had a 
negative correlation (r=0.07, p<0.05). Patients with depression or anxiety had 
lower PCS (difference: -3.5 and -3.7, p<0.05) and MCS (-8.4 and -6.8, p<0.05). 
Patients who had hospitalization due to diabetic ketoacidosis (DKA) reported 
significantly lower PCS (-4.0, p<0.05) and MCS (-2.7, p<0.05). More, number of 
emergency room visits other than for hypoglycemia or DKA was associated with 
lower PCS (Spearman r=-0.05, p<0.05), but not MCS. Patients with an A1c value 
greater than sample median had lower PCS (-2.2, p<0.05) and MCS (-3.6, p<0.05). 
Working patients had higher PCS (4.2, p<0.05) and MCS (1.1, p<0.05). Finally, both 
PCS (r=-0.38, p<0.05) and MCS (r=-0.53, p<0.05) had very strong negative 
correlations with DQoL score. CONCLUSIONS: This study contributed some 
evidence of construct validity of the SF-12 in patients with T1D.  
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OBJECTIVES: Unemployment rates are high among patients with schizophrenia, 
and unemployment has a negative impact upon quality of life. There is also a 
significant societal and economic burden associated with unemployment. Ability 
to work should be considered as a target for treatment with potentially wide-
ranging benefits. However, employment status is dependent on the availability 
of work, stigma of mental illness and cultural influences, and patients’ work 
history and educational background. A clinician-rated scale evaluating readiness 
for work, independent of current work opportunities, would be a potentially 
valuable assessment tool. The objective was to validate a work readiness 
questionnaire, which would allow clinicians to assess and rate patient function 
with respect to ability to engage in useful activity, or work. METHODS: Following 
separate studies to establish content validity and reliability, construct validity 
was evaluated in a global, cross-sectional, observational, stand-alone validation 
study. Two hundred male and female adult outpatients with schizophrenia 
(DSM-IV) were included in the study. Recruitment was oversampled such that 
25% of patients were working independently at the time of assessment. 
RESULTS: Readiness for work was associated with statistically significantly 
higher levels of functioning and lower levels of negative symptoms (P<0.0001). 
For the prediction of current work status, sensitivity was 70% and specificity 
63%. Positive predictive value (PPV) was 32% and negative predictive value (NPV) 
was 89%. The low PPV and high NPV were consistent with the interpretation that 
the scale correctly identifies patients unable to work and not employed, but 
amongst those ready to work, there may be a proportion unable to work due to 
demographic and socioeconomic factors. CONCLUSIONS: The work readiness 
questionnaire was strongly associated with functional outcomes and negative 
symptom severity in the predicted directions and showed high NPV in 
identifying those patients not employed.  
 
PRM110  
ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) SIGNS/ 
SYMPTOMS AND PROS: A COMPREHENSIVE LITERATURE REVIEW  
Cimms TA1, DeBusk K1, Howard K1, Siuciak JA2, Llorens L3, Crawley J4, Halling K5,  
The FNIH Biomarkers Consortium CABP ABSSSI Project Team BC6, Powers JH7 
1Oxford Outcomes Ltd, an ICON plc Company, San Francisco, CA, USA, 2Foundation for the 
National Institutes of Health, Bethesda, MD, USA, 3Cerexa, Inc, Oakland, CA, USA, 4AstraZeneca 
Pharmaceuticals LP, Wilmington, DE, USA, 5AstraZeneca, Mölndal, Sweden, 6The Foundation for 
the National Institutes of Health, Bethesda, MD, USA, 7National Institute of Allergy and 
Infectious Diseases (NIAID) National Institutes of Health (NIH), Bethesda, MD, USA  
OBJECTIVES: The purpose of this literature review was to investigate existing 
patient reported outcome (PRO) measures used in studies of acute bacterial skin 
and skin structure infections (ABSSSI) and to explore signs and symptoms of 
ABSSSI in order to inform the development of a disease model. METHODS: To 
identify relevant abstracts/articles for inclusion a search was conducted in OVID. 
For the purpose of this project, MEDLINE (1946 to present) and EMBASE (1988 to 
2012) were searched using terms for signs and symptoms and existing PRO 
measures, specifically related to skin infections. RESULTS: The search identified 
299 unique abstracts, of which 276 were excluded based on pre-specified 
exclusion criteria. The 23 full-text articles obtained were further reviewed for 
eligibility. The most frequently cited ABSSSI signs/symptoms were redness of 
skin/erythema (n=10), edema (n=7), elevated body temperature (n=7), induration 
(n=6), pain/tenderness of the area, expansion of the lesion, demarcated borders, 
and pus-filled drainage (n=5). No ABSSSI-specific PROs were identified in this 
literature review; however, four of the articles reviewed helped inform the 
development of a disease model. One study employed qualitative interview 
methodology to identify perceived sources of infection, and barriers and 
facilitators to the prevention of CA-MRSA. Three studies involved ABSSSI-related 
patient populations and included PRO measures to assess quality of life. 
CONCLUSIONS: This literature review confirmed that an ABSSSI-specific PRO 
measure has not been cited in the literature, and further exploration of ABSSSI 
signs and symptoms in the form of qualitative interviews with clinicians and 
patients is needed prior to the development of a relevant PRO measure for this 
patient population. The signs and symptoms identified in this literature review 
informed the development of an ABSSSI disease model, which will be used to 
help establish the context of use of the new PRO measure.  
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OBJECTIVES: Probabilistic discrete choice modeling offers an alternative 
approach to exploring values of health states. The aims of this study were: (1) to 
compare whether respondents in the US and Canada differ in their preferences 
for EQ-5D-5L health states using discrete choice experiments (DCE); (2) to explore 
whether US-based respondents differed based on age, gender, race, education 
